JOHNSON JAMES A - Insider Non-Derivative Transactions at Athira Pharma, Inc. (ATHA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 29, 2023, JOHNSON JAMES A's relationship to Athira Pharma, Inc. (ATHA) is Director, and currently has 5,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ATHA insiders.
Data Source: SEC.
JOHNSON JAMES A - Insider Non-Derivative Transactions at ATHA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 30, 2023 | P -- (Common Stock) | 5000 | 2.4 | 5000 |